Last reviewed · How we verify

NCT06606743

Interval Training and Parkinson's Disease

Completed NA Last updated 15 August 2025
What this trial tests

NA trial testing High-Intensity Interval Training in Other Disorders of Autonomic Nervous System in 39 participants. Completed in 30 June 2025.

Timeline
20 September 2024
Primary endpoint
30 June 2025
30 June 2025

Quick facts

Lead sponsorUniversity of Miami
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment39
Start date20 September 2024
Primary completion30 June 2025
Estimated completion30 June 2025
Sites2 locations across United States

Drugs / interventions tested

Conditions studied

Sponsor

University of Miami

Who can join

Adults 30 to 90, any sex, with Other Disorders of Autonomic Nervous System. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This research is designed to compare the impact of high-intensity interval training and high-velocity circuit resistance training on heart rate variability, gait, and functional performance in patients with Parkinsons disease.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of High-Intensity Interval Training

Trials testing the same drug.

Other University of Miami trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06606743.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing